Description
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Purity | ≥95% |
|---|---|
| Formula | C18H25N5O5S |
| Formula Wt. | 423.4 |
| Synonym | MGP-pNa |
| Solubility | Soluble in water. |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
McCarty MF, DiNicolantonio JJ. The molecular biology and pathophysiology of vascular calcification. Postgrad Med. 2014 Mar;126(2):54-64. PMID: 24685968.
Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 2013 Apr;19(4):217-26. PMID: 23375872.
Organosulfur found in garlic; Microtubule polym...
T-type calcium channel blocker
FGFR inhibitor.
pan-PI3K inhibitor.
Mycotoxin.
Polyphenol derivative of caffeic acid found in ...
Aglycone isoflavone found in soy and red clover...
Tropane alkaloid found in Solanaceae plants; M1...
Nucleoside (adenosine) analog found in Tethyra ...
SV2A synaptic vesicle inhibitor.
H+/K+ ATPase and ROCK-2 inhibitor.
Dopamine reuptake inhibitor (DRI).
Immunostimulator, adjuvant.
Histamine H2 inverse agonist.
HDAC1/2/3/11 inhibitor.
Found in Cladosporium; PKC inhibitor.
Statin; HMG-CoA reductase inhibitor.
NK1 antagonist.
NSAID; COX-1/2 and PDE inhibitor.
Cysteine protease inhibitor.